Cargando…

Clinical research of the value of high-risk CTV setting on intensity-modulated radiotherapy for stage IIB-IVA cervical cancer

BACKGROUND: This study aims to evaluate the clinical efficacy and side effects of setting up a high-risk clinical target volume (CTV-hr) alongside simultaneous integrated boost intensity-modulated radiotherapy (IMRT-SIB) in patients diagnosed with stage IIB-IVA cervical cancer. METHODS: This study r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Yuqi, Wang, Jing, Jiang, Peng, Wang, Xiang, Zhang, Lei, Zhang, Yongchun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10225087/ https://www.ncbi.nlm.nih.gov/pubmed/37245053 http://dx.doi.org/10.1186/s12885-023-10931-1

Ejemplares similares

Endu combined with concurrent chemotherapy and radiotherapy for stage IIB-IVA cervical squamous cell carcinoma patients
por: Zhao, Feng-Ju, et al.
Publicado: (2021)

Survival Comparison Between Squamous Cell Carcinoma and Adenocarcinoma for Radiotherapy-Treated Patients with Stage IIB-IVA Cervical Cancer
por: Chen, Fangjie, et al.
Publicado: (2022)

Effect of different surgical approaches on the prognosis of patients with postoperative radiotherapy for stage IIB–IVA esophageal squamous cancer
por: Gao, Mingcheng, et al.
Publicado: (2022)

Recommendation regarding the cranial upper border of level IIb in delineating clinical target volumes (CTV) for nasopharyngeal carcinoma
por: Wang, Lijun, et al.
Publicado: (2020)

Concurrent Chemoradiotherapy With Nedaplatin Versus Cisplatin in Patients With Stage IIB-IVA Cervical Cancer: A Randomized Phase III Trial
por: He, Shasha, et al.
Publicado: (2022)

Cost effectiveness of concurrent gemcitabine and cisplatin and radiation followed by adjuvant gemcitabine and cisplatin in stages IIB–IVA cervical cancer
por: Rajan, Narayan, et al.
Publicado: (2014)

Prognostic significance of PIK3CA mutation in stage IIB to IVA cervical cancers treated by concurrent chemoradiotherapy with weekly cisplatin
por: Lachkar, Bouchra, et al.
Publicado: (2018)

Radiotherapy for stage IVa thymoma—Shanghai Chest experience
por: Wang, Changlu, et al.
Publicado: (2019)

Radical hysterectomy with adjuvant radiotherapy versus radical radiotherapy for FIGO stage IIB cervical cancer
por: Chai, Yanlan, et al.
Publicado: (2014)

Clinical outcomes observation in stage IIB–IIIB cervical cancer treated by adjuvant surgery following concurrent chemoradiotherapy
por: Li, Yong, et al.
Publicado: (2021)

Comparison of concurrent chemoradiation therapy with weekly cisplatin versus monthly fluorouracil plus cisplatin in FIGO stage IIB-IVA cervical cancer
por: Kong, Tae Wook, et al.
Publicado: (2012)

Nedaplatin-based chemotherapy or cisplatin-based chemotherapy combined with intensity-modulated radiotherapy achieve similar efficacy for stage II-IVa nasopharyngeal carcinoma patients
por: Deng, Chao, et al.
Publicado: (2022)

Cost-effectiveness of radical hysterectomy with adjuvant radiotherapy versus radical radiotherapy for FIGO stage IIB cervical cancer
por: Chai, Yanlan, et al.
Publicado: (2016)

The prognostic value of rectal invasion for stage IVA uterine cervical cancer treated with radiation therapy
por: Wakatsuki, Masaru, et al.
Publicado: (2016)

Pulsatility Index and Hypoxia Inducible Factor-1α Expression Predict the Clinical Response after External Radiation in Patients with Stage IIB to IVA Cervical Cancer
por: Winata, I Gde Sastra, et al.
Publicado: (2019)

Variation of endosymbiont and citrus tristeza virus (CTV) titers in the Huanglongbing insect vector, Diaphorina citri, on CTV-infected plants
por: Cui, Xiaoqing, et al.
Publicado: (2023)

Cost-Effectiveness Analysis of Chemoradiation and Radiotherapy Treatment for Stage IIB and IIIB Cervical Cancer Patients
por: Puspitasari, Irma M, et al.
Publicado: (2021)

The Prognostic Value of Deficient Mismatch Repair in Stage II–IVa Nasopharyngeal Carcinoma in the Era of IMRT
por: Chen, Fang-ming, et al.
Publicado: (2020)

Robot-assisted thoracic surgery for stages IIB–IVA non-small cell lung cancer: retrospective study of feasibility and outcome
por: Shahin, Ghada M. M., et al.
Publicado: (2023)

Efficacy and toxicity of image-guided intensity-modulated radiation therapy combined with dose-escalated brachytherapy for stage IIB cervical cancer
por: Wang, Weiping, et al.
Publicado: (2017)

Margin evaluation of translational and rotational set-up errors in intensity modulated radiotherapy for cervical cancer
por: Zhang, Xiang, et al.
Publicado: (2016)

Individualized Concurrent Chemotherapy for Patients with Stage III–IVa Nasopharyngeal Carcinoma Receiving Neoadjuvant Chemotherapy Combined with Definitive Intensity-Modulated Radiotherapy
por: Ji, Pengjie, et al.
Publicado: (2023)

Prognostic Analysis and Comparison of the 2014 and 2018 International Federation of Gynecology and Obstetrics Staging System on Overall Survival in Patients with Stage IIB-IVA Cervix Carcinoma
por: Song, Tao, et al.
Publicado: (2022)

An Adversarial Deep-Learning-Based Model for Cervical Cancer CTV Segmentation With Multicenter Blinded Randomized Controlled Validation
por: Liu, Zhikai, et al.
Publicado: (2021)

Surgical versus clinical staging prior to primary chemoradiation in patients with cervical cancer FIGO stages IIB–IVA: oncologic results of a prospective randomized international multicenter (Uterus-11) intergroup study
por: Marnitz, Simone, et al.
Publicado: (2020)

Prognostic values of the prognostic nutritional index, geriatric nutritional risk index, and systemic inflammatory indexes in patients with stage IIB–III cervical cancer receiving radiotherapy
por: Wang, Hong-Bing, et al.
Publicado: (2023)

Stage IIB-IVA cervix carcinoma in elderly patients treated with radiation therapy: a longitudinal cohort study by propensity score matching analysis
por: Shou, Huafeng, et al.
Publicado: (2023)

Patterns of Cervical Lymph Node Metastasis in Locally Advanced Supraglottic Squamous Cell Carcinoma: Implications for Neck CTV Delineation
por: Xu, Yi, et al.
Publicado: (2020)

Elevated plasma fibrinogen level shows superior prognostic value than Epstein–Barr virus DNA load for stage IVA/B nasopharyngeal carcinoma patients in the intensity-modulated radiotherapy era
por: Lan, Mei, et al.
Publicado: (2016)

Conditional Toxicity Value (CTV) Predictor: An In Silico Approach for Generating Quantitative Risk Estimates for Chemicals
por: Wignall, Jessica A., et al.
Publicado: (2018)

Prognostic value of lymphovascular space invasion in stage IA to IIB cervical cancer: A meta-analysis
por: Huang, Yuan, et al.
Publicado: (2023)

Comparison of outcomes and side effects for neoadjuvant chemotherapy with weekly cisplatin and paclitaxel followed by chemoradiation vs. chemoradiation alone in stage IIB–IVA cervical cancer: study protocol for a randomized controlled trial
por: Li, Jing, et al.
Publicado: (2022)

Tumor residue in patients with stage II–IVA nasopharyngeal carcinoma who received intensity-modulated radiation therapy: development and validation of a prediction nomogram integrating postradiotherapy plasma Epstein–Barr virus deoxyribonucleic acid, clinical stage, and radiotherapy dose
por: Huang, Ying-Ying, et al.
Publicado: (2023)

CTV News | Big Bang machine smashes energy record
Publicado: (2009)

Treatment options for stage IVA thymic malignancies
por: Girard, Nicolas
Publicado: (2019)

Postoperative clinicopathological factors affecting cervical adenocarcinoma: Stages I–IIB
por: Zhou, Jiansong, et al.
Publicado: (2018)

Interfractional change of high-risk CTV D90 during image-guided brachytherapy for uterine cervical cancer
por: Ohkubo, Yu, et al.
Publicado: (2013)

Intraoperative radiotherapy in stage IIB adenocarcinoma of the uterine cervix: a retrospective study
por: Gao, Ying, et al.
Publicado: (2013)

The Effect of Extrafascial Hysterectomy After Completion of External Beam Radiotherapy for Treatment of Locally Advanced Stages (IIB-III) of Cervical Cancer
por: Sarraf, Zahra, et al.
Publicado: (2013)

Pretreatment Systemic Immune-Inflammation Index Can Predict Response to Neoadjuvant Chemotherapy in Cervical Cancer at Stages IB2-IIB
por: Liu, Pingping, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kdosf66gkki56gstgs2d6pmbr4